In agreement with that, there are many examples of so-called Nrf2-addicted cancers bearing mutations in Keap1-Nrf2 system resulting in its permanent activation (reviewed in (Taguchi and Yamamoto, 2020)). This evidence concerns the gene NFE2L2 and cancer.